摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N''-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide | 103981-93-7

中文名称
——
中文别名
——
英文名称
N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N''-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide
英文别名
N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N"-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide
N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N''-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide化学式
CAS
103981-93-7
化学式
C17H33N5O3P
mdl
——
分子量
386.454
InChiKey
YODZWVQNFSXLLQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.56
  • 重原子数:
    26.0
  • 可旋转键数:
    4.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    87.36
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N''-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamidesodium ascorbate 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以58%的产率得到N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N"-<<(2,2,5,5-tetramethyl-1-hydroxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide
    参考文献:
    名称:
    In the search for new anticancer drugs. 19. A predictive design of N,N:N',N':N",N"-tri-1,2-ethanediylphosphoric triamide (TEPA) analogues
    摘要:
    The nitroxyl-labeled analogues of N,N:N',N':N",N"-tri-1,2-ethanediylphosphoric triamide (TEPA), N,N:N',N'-bis(1,2-ethanediyl)-N"-[[(2,2,6,6-tetramethyl-1-oxypiperidi n-4- yl)amino]carbonyl]phosphoric triamide (5a) and N,N:N',N'-bis(1,2-ethanediyl)-N"-[[(2,2,5,5-tetramethyl-1-oxypyrrolid in-3- yl)amino]carbonyl]phosphoric triamide (11a), possess therapeutic indexes that are 8-12 times higher than those of thio-TEPA (1) and TEPA (2). The introduction of methyl groups into the aziridine ring, or the replacement of the nitroxyl moiety with hydroxylamine or amine derivatives, or with an adamantane moiety, results in compounds of lesser activity. An attempt is made to rationalize these results using a lipophilicity scale. A predictive design pattern is established.
    DOI:
    10.1021/jm00161a016
  • 作为产物:
    描述:
    3-氨基-2,2,5,5-四甲基-1-吡咯烷酮N,N-bis(2,2-dimethylaziridinyl)phosphorylurethane甲苯 为溶剂, 反应 0.5h, 以33%的产率得到N,N:N',N'-bis(2-methyl-1,2-propanediyl)-N''-<<(2,2,5,5-tetramethyl-1-oxypyrrolidin-3-yl)amino>carbonyl>phosphoric triamide
    参考文献:
    名称:
    In the search for new anticancer drugs. 19. A predictive design of N,N:N',N':N",N"-tri-1,2-ethanediylphosphoric triamide (TEPA) analogues
    摘要:
    The nitroxyl-labeled analogues of N,N:N',N':N",N"-tri-1,2-ethanediylphosphoric triamide (TEPA), N,N:N',N'-bis(1,2-ethanediyl)-N"-[[(2,2,6,6-tetramethyl-1-oxypiperidi n-4- yl)amino]carbonyl]phosphoric triamide (5a) and N,N:N',N'-bis(1,2-ethanediyl)-N"-[[(2,2,5,5-tetramethyl-1-oxypyrrolid in-3- yl)amino]carbonyl]phosphoric triamide (11a), possess therapeutic indexes that are 8-12 times higher than those of thio-TEPA (1) and TEPA (2). The introduction of methyl groups into the aziridine ring, or the replacement of the nitroxyl moiety with hydroxylamine or amine derivatives, or with an adamantane moiety, results in compounds of lesser activity. An attempt is made to rationalize these results using a lipophilicity scale. A predictive design pattern is established.
    DOI:
    10.1021/jm00161a016
点击查看最新优质反应信息